NasdaqGS - Delayed Quote • USD
PMV Pharmaceuticals, Inc. (PMVP)
At close: April 18 at 4:00 PM EDT
After hours: April 18 at 4:02 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-55,657.0000
-55,657.0000
-63,760.0000
-46,571.0000
-32,739.0000
Investing Cash Flow
-50,545.0000
-50,545.0000
-1,368.0000
-143,584.0000
27,911.0000
Financing Cash Flow
35,577.0000
35,577.0000
958.0000
2,022.0000
292,972.0000
End Cash Position
38,528.0000
38,528.0000
109,119.0000
173,289.0000
361,422.0000
Income Tax Paid Supplemental Data
--
--
--
23.0000
6.0000
Capital Expenditure
-962.0000
-962.0000
-7,984.0000
-1,349.0000
-148.0000
Issuance of Capital Stock
35,121.0000
35,121.0000
--
--
292,966.0000
Free Cash Flow
-56,619.0000
-56,619.0000
-71,744.0000
-47,920.0000
-32,887.0000
12/31/2020 - 9/25/2020
Yahoo Finance Plus Essential access required. Unlock Access
Related Tickers
SEER Seer, Inc.
1.7500
+3.55%
GBIO Generation Bio Co.
2.7800
-6.71%
LYEL Lyell Immunopharma, Inc.
2.3300
-2.10%
IKNA Ikena Oncology, Inc.
1.2600
+1.61%
PRLD Prelude Therapeutics Incorporated
3.4400
-17.70%
ANAB AnaptysBio, Inc.
19.83
-7.64%
TBPH Theravance Biopharma, Inc.
9.20
-3.36%
RZLT Rezolute, Inc.
3.3000
+1.85%
IGMS IGM Biosciences, Inc.
7.41
-8.86%
QNCX Quince Therapeutics, Inc.
1.0600
+6.00%